CPhI Worldwide 2019 Frankfurt Booth 12D16
Drug Establishment Registration on FDA
On Monday, Oct 7, 2019, Jilin Qijian Bio-Pharmaceutical Co.,Ltd. has successfully made the drug establishment registration of HGH raw material on Food and Drug Administration( FDA ).
DMF Number assigned by FDA
The Food and Drug Administration (FDA) acknowledged receipt of our Human Growwth Hormone raw powder Drug Master File(DMF), the DMF assigned number is 33745,DMF type Ⅱ.
CPhI Middle East & Africa
Qijian Bio-Pharmaceutical Co., Ltd will be attending CPhI Middle East & Africa from 16 to 18 September 2019 in Abu Dhabi,UAE. Welcome to visit our booth L60
CPhI South East Asia 2019
Qijian Bio-Pharmaceutical Co., Ltd will be attending CPhI South East Asia 2019 in Bangkok Thailand from Mar. 12th to 14th, weclcome to visit our booth HA34.
Qijian Bio-Pharmaceutical Co., Ltd successfully participated in the 2015 CPHI China Exhibition
Qijian Bio-Pharmaceutical Co., Ltd. participated in the 15th World Pharmaceutical Raw Materials China Exhibition held in Shanghai in June 2015. The exhibition was very successful. Many customers ……
Qijian Bio-Pharmaceutical Co., Ltd Organization employees travel to the ecological farm
In order to let everyone relax and decompress, enhance communication between colleagues and enhance mutual friendship, Jilin Qijian Biotechnology Co., Ltd. organized a trip to the staff farm……